EBV-positive B-cell lymphomas exhibit constitutive activation of TFs, including NF-κB and NFAT (Fu et al., 2006), leading to the transformation of B cells (Price and Luftig, 2014). This evidence concerns the gene NFKB1 and B-cell non-Hodgkin lymphoma.